Baxter International Inc. vs. Sight Sciences, Inc. Common Stock
Baxter International Inc. (BAX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BAX | SGHT | |
|---|---|---|
| Market Cap | $14.24 billion | $411.51 million |
| Revenue (TTM) | $11.47 billion | $83.38 million |
| Net Income (TTM) | $-1,063,000,000 | $-29,757,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | SGHT | |
|---|---|---|
| Price / Book | 2.31 | 7.78 |
| Price / Sales | 1.24 | 4.94 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | SGHT | |
|---|---|---|
| Net Margin | -9.27% | -35.69% |
| Return on Equity | -17.20% | -56.26% |
BAX leads on 2 of 2 profitability factors.
Dividend
| BAX | SGHT | |
|---|---|---|
| Dividend Yield | 0.15% | — |
BAX and SGHT split the dividend factors evenly.
Risk & Sentiment
| BAX | SGHT | |
|---|---|---|
| Short Interest | 1.03% | 0.44% |
SGHT leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, SGHT overview, SGHT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.